Healia
0%
est. 2Y upside i
Modern health insurance for dual income families
Rank
#2040
Sector
Healthtech
Est. Liquidity
~5Y
Data Quality
Data: LowThe equity upside is highly risky and likely worth zero in base and bear cases due to a massive liquidation preference overhang.
Last updated: August 4, 2026
If Healia captures the spousal HRA niche and benefits from an IPO window, exit multiple expands to 10x revenue, yielding a $20.4M exit. This clears the $18M liquidation preference and produces a 4x return, capped by Series A stage.
At a 5x revenue multiple, exit value is only $10.2M, below the $18M preferred stack, leaving common stock worthless. Revenue grows to $2.04M but cannot overcome the preference overhang.
Multiple compresses to 2x revenue, exit value is $4.1M, far below the $18M liquidation preference, so common stock recovers nothing.
Preference Stack Risk
severeFunding Intensity
60000%$18M of preferred stock stands ahead of common; with a $3M current valuation, common stock is deeply underwater.
Dilution Risk
lowWith $18M raised and low burn (28 employees, $1M revenue), the company has multi-year runway; near-term dilution is unlikely.
Secondary Liquidity
nonePrivate company with no secondary activity; equity is illiquid until an IPO or acquisition.
Questions to Ask at the Interview
Strategic questions based on Healia's data — designed to show you've done your homework.
- 1
“How does Healia plan to differentiate from established benefits platforms like Accolade?”
- 2
“What is the employer churn rate and how does subscription pricing scale with family coverage?”
- 3
“What percentage of the current valuation is attributable to common stock versus the liquidation preference?”
Community
Valuation Sentiment
Our model estimates 0% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.